| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | Director | Ordinary Shares | 6.93K | $771K | $111.25 | 08 Aug 2025 | Direct |
| ANAPTYSBIO, INC | Director | Restricted Stock Unit | 3.9K | $85.1K | $21.81 | 06 Jan 2023 | Direct |
| Y-mAbs Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $8.52 | 16 Sep 2025 | Direct |
| Scilex Holding Co | Director | Nonstatutory Stock Option (right to buy) | 250K | 17 Jan 2023 | Direct | ||
| ANAPTYSBIO, INC | Director | Stock Option (right to buy) | 10.6K | 06 Jan 2023 | Direct | ||
| ACCELERON PHARMA INC | Director | Common Stock | 0 | $29.37 | 19 Nov 2021 | Direct | |
| ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | 19 Nov 2021 | Direct | ||
| PARDES BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 0 | 31 Aug 2023 | Direct | ||
| Y-mAbs Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 0 | 16 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| YMAB | Y-mAbs Therapeutics, Inc. | 16 Sep 2025 | 8 | -$50.1K | 4 | Director | 19 Sep 2025, 06:00 |
| JAZZ | Jazz Pharmaceuticals plc | 07 Aug 2025 | 2 | -$201K | 4 | Director | 11 Aug 2025, 17:44 |
| YMAB | Y-mAbs Therapeutics, Inc. | 30 Jun 2025 | 2 | $0 | 4 | Director | 02 Jul 2025, 16:20 |
| JAZZ | Jazz Pharmaceuticals plc | 02 Aug 2024 | 1 | $0 | 4 | Director | 06 Aug 2024, 16:48 |
| JAZZ | Jazz Pharmaceuticals plc | 25 Jul 2024 | 0 | $0 | 3 | Director | 30 Jul 2024, 20:11 |
| YMAB | Y-mAbs Therapeutics, Inc. | 11 Jun 2024 | 2 | $0 | 4 | Director | 13 Jun 2024, 21:02 |
| PRDS | PARDES BIOSCIENCES, INC. | 31 Aug 2023 | 4 | $0 | 4 | Director | 31 Aug 2023, 14:36 |
| YMAB | Y-mAbs Therapeutics, Inc. | 08 Jun 2023 | 2 | $0 | 4 | Director | 09 Jun 2023, 18:05 |
| PRDS | PARDES BIOSCIENCES, INC. | 01 Jun 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 16:06 |
| SCLX | Scilex Holding Co | 17 Jan 2023 | 1 | $0 | 4 | Director | 17 Jan 2023, 16:30 |
| ANAB | ANAPTYSBIO, INC | 06 Jan 2023 | 2 | $0 | 4 | Director | 10 Jan 2023, 18:07 |
| SCLX | Vickers Vantage Corp. I | 10 Nov 2022 | 0 | $0 | 3 | Director | 15 Nov 2022, 17:31 |
| YMAB | Y-mAbs Therapeutics, Inc. | 15 Jul 2022 | 1 | $0 | 4 | Director | 19 Jul 2022, 13:24 |
| PRDS | PARDES BIOSCIENCES, INC. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:25 |
| ANAB | ANAPTYSBIO, INC | 10 Feb 2022 | 1 | $0 | 4 | Director | 14 Feb 2022, 15:53 |
| PRDS | PARDES BIOSCIENCES, INC. | 23 Dec 2021 | 1 | $0 | 4 | Director | 28 Dec 2021, 15:31 |
| PRDS | PARDES BIOSCIENCES, INC. | 23 Dec 2021 | 0 | $0 | 3 | Director | 27 Dec 2021, 16:50 |
| XLRN | ACCELERON PHARMA INC | 19 Nov 2021 | 3 | $0 | 4 | Director | 22 Nov 2021, 08:07 |
| YMAB | Y-mAbs Therapeutics, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 17:06 |